An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Patel, M.Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med. 2004;37(12):1951–1962.10.1016/j.freeradbiomed.2004.08.021CrossRefGoogle ScholarPubMed
2
Wallace, DC.A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359–407.10.1146/annurev.genet.39.110304.095751CrossRefGoogle ScholarPubMed
3
Andreazza, AC, Kauer-Sant’Anna, M, Frey, BN, et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disorders. 2008;111(2-3):135–144.10.1016/j.jad.2008.04.013CrossRefGoogle ScholarPubMed
4
Patel, M.A metabolic paradigm for epilepsy. Epilepsy Curr. 2018;18(5):318–322.10.5698/1535-7597.18.5.318CrossRefGoogle ScholarPubMed
5
Ji, D, Mylvaganam, S, Ravi Chander, P, Tarnopolsky, M, Murphy, K, Carlen, P.Mitochondria and oxidative stress in epilepsy: advances in antioxidant therapy. Front Pharmacol. 2025;15:1505867. https://doi.org/10.3389/fphar.2024.1505867.CrossRefGoogle ScholarPubMed
6
Zachos, KA, Gamboa, JA, Dewji, AS, Lee, J, Brijbassi, S, Andreazza, AC.The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease. Front Pharmacol. 2024;15:1428242.10.3389/fphar.2024.1428242CrossRefGoogle ScholarPubMed
7
Abdelmalik, PA, Politzer, N, Carlen, PL.Magnesium as an effective adjunct therapy for drug resistant seizures. Can J Neurol Sci. 2012;39(3):323–327.10.1017/S0317167100013457CrossRefGoogle Scholar